Works matching DE "EPIDERMAL growth factor receptor genetics"


Results: 77
    1
    2
    3
    4
    5
    6
    7
    8

    Second Line Treatment in EGFR/ALK-NSCLC Patients.

    Published in:
    Journal of OncoPathology, 2015, v. 3, n. 1, p. 55, doi. 10.13032/tjop.2052-5931.100119
    By:
    • Morán, Teresa;
    • Vilà, Laia;
    • de los Llanos Gil, Maria;
    • Indacochea, Alberto;
    • Hardy-Werbin, Max;
    • Carcereny, Enric;
    • Remón, Jordi;
    • Rosell, Rafael
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20

    Circulating Tumor Cells Identify Early Recurrence in Patients with Non-Small Cell Lung Cancer Undergoing Radical Resection.

    Published in:
    PLoS ONE, 2016, v. 11, n. 2, p. 1, doi. 10.1371/journal.pone.0148659
    By:
    • Bayarri-Lara, Clara;
    • Ortega, Francisco G.;
    • Cueto Ladrón de Guevara, Antonio;
    • Puche, Jose L.;
    • Ruiz Zafra, Javier;
    • de Miguel-Pérez, Diego;
    • Ramos, Abel Sánchez-Palencia;
    • Giraldo-Ospina, Carlos Fernando;
    • Navajas Gómez, Juan A.;
    • Delgado-Rodriguez, Miguel;
    • Lorente, Jose A.;
    • Serrano, María Jose
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39

    Gefitinib versus pemetrexed as second-line treatment in patients with nonsmall cell lung cancer previously treated with platinum-based chemotherapy (KCSG-LU08-01).

    Published in:
    Cancer (0008543X), 2012, v. 118, n. 24, p. 6234, doi. 10.1002/cncr.27630
    By:
    • Sun, Jong-Mu;
    • Lee, Ki Hyeong;
    • Kim, Sang-we;
    • Lee, Dae Ho;
    • Min, Young Joo;
    • Yun, Hwan Jung;
    • Kim, Hoon Kyo;
    • Song, Hong Suk;
    • Kim, Yeul Hong;
    • Kim, Bong-Seog;
    • Hwang, In Gyu;
    • Lee, Keehyun;
    • Jo, Sook Jung;
    • Lee, Jae Won;
    • Ahn, Jin Seok;
    • Park, Keunchil;
    • Ahn, Myung-Ju
    Publication type:
    Article
    40
    41
    42
    43
    44
    46
    47
    48

    Factor associated with failure to administer subsequent treatment after progression in the first-line chemotherapy in EGFR-mutant non-small cell lung cancer: Okayama Lung Cancer Study Group experience.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 5, p. 943, doi. 10.1007/s00280-014-2425-9
    By:
    • Kato, Yuka;
    • Hotta, Katsuyuki;
    • Takigawa, Nagio;
    • Nogami, Naoyuki;
    • Kozuki, Toshiyuki;
    • Sato, Akiko;
    • Ichihara, Eiki;
    • Kudo, Kenichiro;
    • Oze, Isao;
    • Tabata, Masahiro;
    • Shinkai, Tetsu;
    • Tanimoto, Mitsune;
    • Kiura, Katsuyuki
    Publication type:
    Article
    49
    50